LY451395

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY451395, covering 2006-07-19 to 2006-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease [Phase 2]